ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ARDT - US03980N1072 - Common Stock
8.82 USD
+0.01 (+0.11%)
8.99 USD
+0.17 (+1.93%)
ARDT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. ARDT has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on ARDT. These ratings could make ARDT a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year ARDT was profitable.
ARDT had a positive operating cash flow in the past year.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.98%, ARDT is in the better half of the industry, outperforming 69.61% of the companies in the same industry.
Looking at the Return On Equity, with a value of 16.56%, ARDT belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
ARDT has a better Return On Invested Capital (7.53%) than 69.61% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ARDT is below the industry average of 9.61%.
The last Return On Invested Capital (7.53%) for ARDT is above the 3 year average (5.96%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.98% | ||
| ROE | 16.56% | ||
| ROIC | 7.53% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of ARDT (3.24%) is better than 68.63% of its industry peers.
ARDT's Profit Margin has improved in the last couple of years.
The Operating Margin of ARDT (5.98%) is better than 65.69% of its industry peers.
In the last couple of years the Operating Margin of ARDT has grown nicely.
ARDT has a better Gross Margin (57.94%) than 81.37% of its industry peers.
ARDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.98% | ||
| PM (TTM) | 3.24% | ||
| GM | 57.94% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ARDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ARDT has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ARDT has been reduced compared to a year ago.
2.2 Solvency
ARDT has an Altman-Z score of 2.02. This is not the best score and indicates that ARDT is in the grey zone with still only limited risk for bankruptcy at the moment.
ARDT has a Altman-Z score of 2.02. This is comparable to the rest of the industry: ARDT outperforms 45.10% of its industry peers.
The Debt to FCF ratio of ARDT is 7.03, which is on the high side as it means it would take ARDT, 7.03 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.03, ARDT is in line with its industry, outperforming 58.82% of the companies in the same industry.
A Debt/Equity ratio of 0.88 indicates that ARDT is somewhat dependend on debt financing.
ARDT's Debt to Equity ratio of 0.88 is in line compared to the rest of the industry. ARDT outperforms 42.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 7.03 | ||
| Altman-Z | 2.02 |
ROIC/WACC0.88
WACC8.55%
2.3 Liquidity
ARDT has a Current Ratio of 2.08. This indicates that ARDT is financially healthy and has no problem in meeting its short term obligations.
ARDT has a better Current ratio (2.08) than 79.41% of its industry peers.
ARDT has a Quick Ratio of 1.95. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
ARDT's Quick ratio of 1.95 is amongst the best of the industry. ARDT outperforms 80.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 314.38% over the past year.
Measured over the past years, ARDT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.75% on average per year.
The Revenue has grown by 10.29% in the past year. This is quite good.
The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%
3.2 Future
Based on estimates for the next years, ARDT will show a small growth in Earnings Per Share. The EPS will grow by 5.15% on average per year.
Based on estimates for the next years, ARDT will show a small growth in Revenue. The Revenue will grow by 7.17% on average per year.
EPS Next Y-9.9%
EPS Next 2Y4.28%
EPS Next 3Y5.15%
EPS Next 5YN/A
Revenue Next Year8.56%
Revenue Next 2Y6.44%
Revenue Next 3Y6.09%
Revenue Next 5Y7.17%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 4.12, the valuation of ARDT can be described as very cheap.
Based on the Price/Earnings ratio, ARDT is valued cheaper than 99.02% of the companies in the same industry.
ARDT is valuated cheaply when we compare the Price/Earnings ratio to 26.61, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.60 indicates a rather cheap valuation of ARDT.
Based on the Price/Forward Earnings ratio, ARDT is valued cheaper than 97.06% of the companies in the same industry.
ARDT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.12 | ||
| Fwd PE | 6.6 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ARDT is valued cheaply inside the industry as 98.04% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ARDT is valued cheaply inside the industry as 89.22% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.02 | ||
| EV/EBITDA | 3.31 |
4.3 Compensation for Growth
ARDT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.28%
EPS Next 3Y5.15%
5. Dividend
5.1 Amount
ARDT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.82
+0.01 (+0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.82%
Inst Owner Change2.1%
Ins Owners1.98%
Ins Owner Change-0.01%
Market Cap1.26B
Revenue(TTM)6.33B
Net Income(TTM)205.06M
Analysts77.89
Price Target14.83 (68.14%)
Short Float %2.47%
Short Ratio4.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.03%
Min EPS beat(2)24.85%
Max EPS beat(2)71.2%
EPS beat(4)4
Avg EPS beat(4)53.83%
Min EPS beat(4)24.85%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.13%
Min Revenue beat(2)-0.08%
Max Revenue beat(2)4.33%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.01%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.51%
PT rev (3m)-25.25%
EPS NQ rev (1m)-41.58%
EPS NQ rev (3m)-51.15%
EPS NY rev (1m)-40.94%
EPS NY rev (3m)-40.82%
Revenue NQ rev (1m)-0.42%
Revenue NQ rev (3m)-1.54%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.12 | ||
| Fwd PE | 6.6 | ||
| P/S | 0.2 | ||
| P/FCF | 8.02 | ||
| P/OCF | 3.44 | ||
| P/B | 1.02 | ||
| P/tB | 4.67 | ||
| EV/EBITDA | 3.31 |
EPS(TTM)2.14
EY24.26%
EPS(NY)1.34
Fwd EY15.16%
FCF(TTM)1.1
FCFY12.47%
OCF(TTM)2.56
OCFY29.03%
SpS44.18
BVpS8.65
TBVpS1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.98% | ||
| ROE | 16.56% | ||
| ROCE | 8.99% | ||
| ROIC | 7.53% | ||
| ROICexc | 8.81% | ||
| ROICexgc | 12.04% | ||
| OM | 5.98% | ||
| PM (TTM) | 3.24% | ||
| GM | 57.94% | ||
| FCFM | 2.49% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 7.03 | ||
| Debt/EBITDA | 2.05 | ||
| Cap/Depr | 137.15% | ||
| Cap/Sales | 3.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.06% | ||
| Profit Quality | 76.79% | ||
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.95 | ||
| Altman-Z | 2.02 |
F-Score8
WACC8.55%
ROIC/WACC0.88
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
EPS Next Y-9.9%
EPS Next 2Y4.28%
EPS Next 3Y5.15%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%
Revenue Next Year8.56%
Revenue Next 2Y6.44%
Revenue Next 3Y6.09%
Revenue Next 5Y7.17%
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year53.32%
EBIT Next 3Y17.57%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A
ARDENT HEALTH INC / ARDT FAQ
Can you provide the ChartMill fundamental rating for ARDENT HEALTH INC?
ChartMill assigns a fundamental rating of 5 / 10 to ARDT.
What is the valuation status of ARDENT HEALTH INC (ARDT) stock?
ChartMill assigns a valuation rating of 8 / 10 to ARDENT HEALTH INC (ARDT). This can be considered as Undervalued.
Can you provide the profitability details for ARDENT HEALTH INC?
ARDENT HEALTH INC (ARDT) has a profitability rating of 6 / 10.
What is the expected EPS growth for ARDENT HEALTH INC (ARDT) stock?
The Earnings per Share (EPS) of ARDENT HEALTH INC (ARDT) is expected to decline by -9.9% in the next year.